Megace ES Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Megace ES
P
- Pacaps (acetaminophen / butalbital / caffeine)
- pacritinib
- PB-Hyos (atropine / hyoscyamine / phenobarbital / scopolamine)
- PCE Dispertab (erythromycin)
- Pediazole (erythromycin / sulfisoxazole)
- pentobarbital
- pexidartinib
- Pharmagesic (acetaminophen / butalbital / caffeine)
- Phenaz Plus (butabarbital / hyoscyamine / phenazopyridine)
- PhenazoForte Plus (butabarbital / hyoscyamine / phenazopyridine)
- phenobarbital
- Phenohytro (atropine / hyoscyamine / phenobarbital / scopolamine)
- phenylbutazone
- Phenytek (phenytoin)
- phenytoin
- Phenytoin Sodium (phenytoin)
- Phenytoin Sodium, Extended Release (phenytoin)
- Phenytoin Sodium, Prompt (phenytoin)
- Phrenilin (acetaminophen / butalbital)
- Phrenilin Forte (acetaminophen / butalbital / caffeine)
- Phrenilin Forte (old formulation) (acetaminophen / butalbital)
- Phrenilin with Caffeine and Codeine (acetaminophen / butalbital / caffeine / codeine)
- pioglitazone
- posaconazole
- pramlintide
- PrandiMet (metformin / repaglinide)
- Prandin (repaglinide)
- Precose (acarbose)
- Prevalite (cholestyramine)
- Prevpac (amoxicillin / clarithromycin / lansoprazole)
- Prevymis (letermovir)
- Prezcobix (cobicistat / darunavir)
- Prezista (darunavir)
- Priftin (rifapentine)
- primidone
- Promacet (acetaminophen / butalbital)
- Prominol (acetaminophen / butalbital)
- Protropin (somatrem)
- Provigil (modafinil)
- Pyrelle HB (butabarbital / hyoscyamine / phenazopyridine)
- Pyridium Plus (butabarbital / hyoscyamine / phenazopyridine)
- Pyrukynd (mitapivat)
More about Megace ES (megestrol)
- Megace ES consumer information
- Check interactions
- Compare alternatives
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: hormones/antineoplastics
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.